ReviewJOR spine2025
The Impact of the Ovine Annular Lesion Model on IVD Pathobiology and Utility of the Ovine Spinal Model in Patho-Anatomical Studies: A Historical Perspective.
Review in JOR spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mechanotransduction in intervertebral disc degeneration: from compartment-specific sensors to translational frontiers.Frontiers in bioengineering and biotechnology · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review documents the impact of the Osti ovine annular lesion model of intervertebral disc (IVD) degeneration on the elucidation of degenerative changes in the ovine IVD also seen in human IVD degeneration (IVDD). The degenerative pathology knowledge base generated by the ovine model over the last 35 years has provided invaluable insights into degenerative events occurring in the human IVD. Changes in para-discal structures as a consequence of IVDD, in vertebral bone adjacent to the lesion site, cartilaginous endplates and spinal motion segment facet joints, and in the longitudinal ligaments and paraspinal muscles also affect spinal stability and flexibility. All of these spinal structures are richly innervated, and disturbance of their normal architecture due to IVDD also contributes to the generation of low back pain. Like human IVDD, when the ovine IVD is mechanically destabilized by the introduction of a controlled annular lesion, release of proteases is elevated, degradation of structural ECM components occurs, leading to IVDD and biomechanical impairment. When space-filling aggrecan is degraded in the IVD, a drop in internal hydrostatic pressure occurs, and the IVD becomes susceptible to an ingrowth of blood vessels and mechanosensitive nociceptors resulting in enhanced generation of low back pain by the biomechanically incompetent IVD. The ovine model is thus very useful to evaluate compounds or procedures that slow IVDD and, in some cases, promote regenerative processes. The large size of the ovine IVD allows the use of inter-disciplinary longitudinal approaches in the analysis of progressive changes in the degenerate IVD of relevance to the human IVD. Clinical Significance: The ovine annular lesion model of IVDD displays similar pathological features to those displayed by the degenerate human IVD, making it an appropriate model for the evaluation of IVD reparative procedures. Furthermore, the resident ovine IVD cell populations are similar to those seen in the human IVD, with a disappearance of notochordal cells occurring in adolescence. This is not the case in many other popular animal (murine, rat, porcine, lapine, and non-chondrodystrophic canine) models of IVDD. The persistence of notochordal cells into adulthood in these breeds questions how translatable findings generated in these models are to the human IVD. The ovine model is thus relevant to the development of strategies exploring novel strategies in IVD repair and the recovery of normal IVD structure and function. Mesenchymal stem cells have impressive IVD repair and recovery of structure and function properties, showing promise in the treatment of the degenerate human IVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.